Intralesional administration of interferon A for the management of severe haemangiomas

Pediatric Surgery International

Volumn 23, Issue 3, 2007, Pages 215-218

  Kaselas, C ^a   Tsikopoulos, G ^a   Papouis, G ^a   Kaselas, V ^a  

^a Aristotle University of Thessaloniki   (Greece)

Author keywords

Haemangioma; Interferon A; Intralesional administration

Indexed keywords

ALPHA INTERFERON; ANTIPYRETIC AGENT; PARACETAMOL;

ARTICLE; BODY SURFACE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG TOLERANCE; DRUG WITHDRAWAL; FEMALE; FEVER; HEMANGIOMA; HUMAN; INFANT; MALAISE; MALE; NEUTROPENIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIODIAGNOSIS; TACHYCARDIA; TREATMENT DURATION;

ANGIOGENESIS INHIBITORS; CHILD, PRESCHOOL; FEMALE; HEMANGIOMA; HUMANS; INFANT; INJECTIONS, INTRALESIONAL; INTERFERON-ALPHA; MALE; SKIN NEOPLASMS; SOFT TISSUE NEOPLASMS;

EID: 33847144896     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-006-1840-3     Document Type: Article

References (19)

1. Silverman RA (1991) Hemangiomas and vascular malformations. Ped Clin North Am 38:811-834
2. Weber TR, Connors RH, Tracy TF, Bailey PV (1990) Complex hemangiomas of infants and children: individual management in 22 cases. Arch Surg 125:1017-1021
3. Chen MT, Yeong EW, Horug SY (2000) Intralesional corticosteroids therapy in proliferative head and neck hemangiomas: a review of 155 cases. J Ped Surg 35(3):420-423
4. Moore J, Lee M, Gazzon M et al (2001) Effective therapy of a vascular tumor of infancy with vincristine. J Ped Surg 36(8):1273-1276
5. Marler JJ, Rubin JB, Trede NS et al (2002) Successful antiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: report of 2 cases. Pediatrics 109(2):E37
6. Miller SH, Smith RL, Schochut SJ (1976) Compression treatment of hemangiomas. Plast Surg 58:573-579
7. Goldwyn RM, Rosoff CB (1969) Cryosurgery for large hemangiomas in adults. Plast Reconstr Surg 43:605-611
8. Riche MC, Hadjean E, Tran BH et al (1983) The treatment of capillary venous malformations using a new fibrosing agent. Plast Reconstr Surg 71:607-614
9. Brouty-Boye D, Zetter B (1980) Inhibition of cell motility by interferon. Science 208:516-518
10. Sidky Y, Borden EC (1987) Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte- induced vascular responses. Cancer Res 47:5155-5161
11. Lindner DJ (2002) Interferons as antiangiogenic agents. Curr Oncol Rep 4(6):510-514
12. Lloret P (2004) Medical treatment of haemangiomas. An Sist Sanit Navar 27(Suppl 1):81-92
13. Damas Mateache B, Menendez Suso JJ, Abelairas Gomez JM, Albajara Velasco L, Peralta Calvo J, Verdu Sanchez C, Royo Orejas A (2003) Interferon alpha and infantile orbital hemangioma. Arch Soc Esp Oftalmol 78(11):623-629
14. Fledelius HC, Illum N, Jensen H, Prause JU (2001) Interferon-alfa treatment of facial infantile haemangiomas: with emphasis on the sight-threatening varieties. A clinical series. Acta Ophthalmol Scand 79(4):370-373
15. Grimal I, Duveau E, Enjolras O, Verret JL, Ginies JL (2000) Effectiveness and dangers of interferon- alpha in the treatment of severe hemangiomas in infants. Arch Pediatr 7(2):163-167
16. Schiavetti A, De Pasquale MD, Di Salvo S, Ventriglia F, Clerico A (2003) Recombinant interferon alfa 2a in hepatic hemangiomatosis with congestive heart failure: a case report. Pediatr Hematol Oncol 20(2):161-165
17. Dubois J, Hershon L, Carmant L, Belanger S, Leclerc JM, David M (1999) Toxicity profile of interferon alfa-2b in children: a prospective evaluation. J Pediatr 135(6):782-785
18. Garmendia G, Miranda N, Borosso S, Longchong M, Martinez E, Ferrero J, Porrero P, Lopez-Saura P (2001) Regression of infancy hemangiomas with recombinant IFN-alpha 2b. J Interferon Cytokine Res 21(1):31-38
19. Tamayo L, Ortiz DM, Orozco-Covarrubias L, Duran-McKinster C, Mora MA, Avila E, Teixeira F, Ruiz-Maldonado R (1997) Therapeutic efficacy of interferon alfa-2b in infants with life threatening giant hemangiomas. Arch Dermatol 133(12):1567-1571